RECURRENT EPITHELIAL CANCER OF OVARY

Clinical trials for RECURRENT EPITHELIAL CANCER OF OVARY explained in plain language.

Never miss a new study

Get alerted when new RECURRENT EPITHELIAL CANCER OF OVARY trials appear

Sign up with your email to follow new studies for RECURRENT EPITHELIAL CANCER OF OVARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy aims to fight back against recurrent ovarian cancer

Disease control Ongoing

This study is testing whether adding an experimental drug called oregovomab to an existing cancer drug, niraparib, can help control recurrent ovarian cancer. It will involve about 10 women whose cancer returned but initially responded well to platinum-based chemotherapy. The main…

Matched conditions: RECURRENT EPITHELIAL CANCER OF OVARY

Phase: PHASE2 • Sponsor: CanariaBio Inc. • Aim: Disease control

Last updated Apr 13, 2026 20:19 UTC

RECURRENT EPITHELIAL CANCER OF OVARY

Get alerted when new RECURRENT EPITHELIAL CANCER OF OVARY trials appear

New combo therapy aims to fight back against recurrent ovarian cancer